Faisal Khurshid

Faisal Khurshid has a diverse range of work experience in various industries. Faisal is currently working as a Vice President of Equity Research at Leerink Partners, starting in April 2021. Prior to this, they worked as an Engagement Director and BD Lead at Axiom Healthcare Strategies from 2017 to 2021. Faisal also served as a Visiting Fellow at Moores Cancer Center in 2020, where they collaborated with Dr. Hatim Husain on analyzing the genomic landscape and therapeutic developments in lung cancer. Before joining Axiom, Faisal worked as a Strategy Consultant at ClearView Healthcare Partners from 2015 to 2017. Faisal also gained experience as a Research Scientist at Brown University/Takeda Pharmaceuticals from 2013 to 2015 and as an R&D Engineer at Arsenal Medical in 2014. Overall, Faisal Khurshid has demonstrated expertise in equity research, healthcare strategies, oncology research, consulting, and engineering.

Faisal Khurshid completed their education in Biomedical/Medical Engineering at Brown University between an unspecified start year and 2016. In 2021, they obtained certifications such as SIE, Series 63, Series 86, and Series 87 from FINRA.